STERIS (STE) Stock Forecast & Price Target

STERIS
Bear Case

Investors should be bearish about investing in STERIS plc for these reasons:

• STERIS plc is trading at a P/E ratio of 26.77, which is relatively high compared to the broader market, and some analysts, such as Weiss Ratings, have issued a "hold" rating, suggesting that the current stock price may already fully price in the company's expected cash flow growth and future earnings potential.
• Recent insider activity shows a trend of selling, with Director Mohsen Sohi selling 4,058 shares in August 2026 and CEO Daniel A. Carestio selling shares in June 2026, which may signal that company insiders are taking advantage of the current valuation to reduce their personal exposure to the stock.
• The stock has experienced volatility and recently traded near its 52-week low of $195.14 in early 2026, indicating that the market has been uncertain about the company's performance, and the current price of $219.01 is still significantly below its 52-week high of $269.44, reflecting a period of underperformance relative to its peak valuation.
• Short interest in STERIS plc has been increasing, with shares shorted rising to 2,857,327 as of September 30, 2026, representing a 2.47% month-over-month increase, which suggests that a growing number of investors are betting against the stock's future price appreciation, potentially due to concerns about valuation or competitive pressures.
• The company's recent acquisition of Xodus Medical for $2.1 billion, while strategically sound, represents a significant capital outlay that may pressure free cash flow in the near term and could lead to integration challenges, potentially impacting the company's ability to maintain its current dividend yield and growth trajectory if the acquisition does not perform as expected.